/ 首页 / 产品中心 / 高级中间体 / Anti-Cancer /

Trametinib Intermediate

N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,7,8-tetrahydropyrido[2,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide DMSO solvate
CAS号
1187431-43-1
分子式
C28H29FIN5O5S
分子量
693.53
纯度
98%
适应症
Trametinib Intermediate
产品描述

n May 2013, the US FDA approved trametinib (also referred to as GSK1120212 and JTP-74057), for the treatment of patients with unresectable or metastatic melanoma with BRAFV600e or BRAFV600K mutations as detected by an FDA-approved test